Skip to main content

Advertisement

SpringerLink
Log in

A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up

  • CLINICAL TRAIL
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Purpose To determine the long-term overall survival of male patients with stage II node positive breast cancer treated with adjuvant chemotherapy.

Patients and methods Between 1974 and 1988, 31 male breast cancer patients were prospectively enrolled on study MB-82 in the National Cancer Institute. Following mastectomy, patients were treated with 12 cycles of cyclophosphamide, methotrexate, and fluorouracil (CMF) chemotherapy.

Results Median patient age was 61 years (38–74 years). Twenty-one patients (68%) had 1–3 positive axillary lymph nodes while ten patients (32%) had four or more positive nodes. Estrogen receptor status was positive in 22 (71%), negative in 1 (3%), and unknown in 8 (26%) tumors. Progesterone receptor status was positive in 18 (58%), negative in 3 (10%), and unknown in 10 (32%) tumors. Median potential follow-up for all patients is 22.5 years with a median survival of 16.3 years. Twenty-one of 31 patients have died; one from a treatment-related complication, nine patients from recurrent breast cancer, five from other cancers, one from non-cancer related causes, and five from unknown causes. Ten patients remain alive at a median of 19.2 years. The overall survival probability at 10 years is 64.5% (95% CI: 46.9–78.9%), at 15 years is 51.6% (95% CI: 34.8–68%), and at 20 years is 42.4% (95% CI: 25.8–60.8%).

Conclusion To our knowledge, 20-year prospective data with adjuvant chemotherapy in male breast cancer has never been reported. Adjuvant chemotherapy may benefit male breast cancer patients with positive nodes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E et al (2006) Cancer statistics, 2006. CA Cancer J Clin 56(2):106–130

    PubMed  Google Scholar 

  2. Giordano SH, Cohen DS, Buzdar AU et al (2004) Breast carcinoma in men: a population-based study. Cancer 101(1):51–57

    Article  PubMed  Google Scholar 

  3. Anderson WF, Devesa SS (2005) In situ male breast carcinoma in the Surveillance, Epidemiology, and End Results database of the National Cancer Institute. Cancer 104(8):1733–1741

    Article  PubMed  Google Scholar 

  4. Wainwright J (1927) Carcinoma of the male breast. Arch Surg 14:836–859

    Google Scholar 

  5. Heller KS, Rosen PP, Schottenfeld D et al (1978) Male breast cancer: a clinicopathologic study of 97 cases. Ann Surg 188(1):60–65

    Article  PubMed  CAS  Google Scholar 

  6. Ramantanis G, Besbeas S, Garas JG (1980) Breast cancer in the male: a report of 138 cases. World J Surg 4(5):621–623

    Article  PubMed  CAS  Google Scholar 

  7. Stierer M, Rosen H, Weitensfelder W et al (1995) Male breast cancer: Austrian experience. World J Surg 19(5):687–692; discussion 692–683

    Article  PubMed  CAS  Google Scholar 

  8. Donegan WL, Redlich PN, Lang PJ et al (1998) Carcinoma of the breast in males: a multiinstitutional survey. Cancer 83(3):498–509

    Article  PubMed  CAS  Google Scholar 

  9. Erlichman C, Murphy KC, Elhakim T (1984) Male breast cancer: a 13-year review of 89 patients. J Clin Oncol 2(8):903–909

    PubMed  CAS  Google Scholar 

  10. Yap HY, Tashima CK, Blumenschein GR et al (1979) Male breast cancer: a natural history study. Cancer 44(2):748–754

    Article  PubMed  CAS  Google Scholar 

  11. Salvadori B, Saccozzi R, Manzari A et al (1994) Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer 30A(7):930–935

    Article  PubMed  CAS  Google Scholar 

  12. Cutuli B, Lacroze M, Dilhuydy JM et al (1995) Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer 31A(12):1960–1964

    Article  PubMed  CAS  Google Scholar 

  13. Guinee VF, Olsson H, Moller T et al (1993) The prognosis of breast cancer in males. A report of 335 cases. Cancer 71(1):154–161

    Article  PubMed  CAS  Google Scholar 

  14. Goss PE, Reid C, Pintilie M et al (1999) Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer 85(3):629–639

    Article  PubMed  CAS  Google Scholar 

  15. Spence RA, MacKenzie G, Anderson JR et al (1985) Long-term survival following cancer of the male breast in Northern Ireland. A report of 81 cases. Cancer 55(3):648–652

    Article  PubMed  CAS  Google Scholar 

  16. Yildirim E, Berberoglu U (1998) Male breast cancer: a 22-year experience. Eur J Surg Oncol 24(6):548–552

    Article  PubMed  CAS  Google Scholar 

  17. Ribeiro GG (1977) Carcinoma of the male breast: a review of 200 cases. Br J Surg 64(6):381–383

    Article  PubMed  CAS  Google Scholar 

  18. Ribeiro G (1985) Male breast carcinoma—a review of 301 cases from the Christie Hospital & Holt Radium Institute, Manchester. Br J Cancer 51(1):115–119

    PubMed  CAS  Google Scholar 

  19. Crichlow RW (1974) Breast cancer in men. Semin Oncol 1(2):145–152

    PubMed  CAS  Google Scholar 

  20. Ribeiro G, Swindell R, Harris M et al (1996) A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. Breast 5:141–146

    Article  Google Scholar 

  21. Robison R, Montague ED (1982) Treatment results in males with breast cancer. Cancer 49(2):403–406

    Article  PubMed  CAS  Google Scholar 

  22. Appelqvist P, Salmo M (1982) Prognosis in carcinoma of the male breast. Acta Chir Scand 148(6):499–502

    PubMed  CAS  Google Scholar 

  23. Crichlow RW (1972) Carcinoma of the male breast. Surg Gynecol Obstet 134(6):1011–1019

    PubMed  CAS  Google Scholar 

  24. Bonadonna G, Brusamolino E, Valagussa P et al (1976) Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 294(8):405–410

    Article  PubMed  CAS  Google Scholar 

  25. Bagley CS, Wesley MN, Young RC et al (1987) Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol 10(1):55–60

    Article  PubMed  CAS  Google Scholar 

  26. Beahrs OH, Myers M (eds) (1983) Manual for staging of cancer-american joint committee on cancer. J.B. Lippincott Co., Philadelphia

    Google Scholar 

  27. Kaplan E, Meier P (1958) Non-parametric estimation from incomplete observation. J Am Statist Assoc 53:457–481

    Article  Google Scholar 

  28. Surveillance, Epidemiology, End results (SEER) Program (www.seer.cancer.gov) SEER STAT database: Incidence- SEER 17 Regs Public-use; November 2005 submission for survival analyses [1973–2003 varying], National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006

  29. Patel HZ II, Buzdar AU, Hortobagyi GN (1989) Role of adjuvant chemotherapy in male breast cancer. Cancer 64(8):1583–1585

    Article  PubMed  Google Scholar 

  30. Izquierdo MA, Alonso C, De Andres L et al (1994) Male breast cancer. Report of a series of 50 cases. Acta Oncol 33(7):767–771

    PubMed  CAS  Google Scholar 

  31. Giordano SH, Perkins GH, Broglio K et al (2005) Adjuvant systemic therapy for male breast carcinoma. Cancer 104(11):2359–2364

    Article  PubMed  Google Scholar 

  32. Rosenblatt KA, Thomas DB, McTiernan A et al (1991) Breast cancer in men: aspects of familial aggregation. J Natl Cancer Inst 83(12):849–854

    Article  PubMed  CAS  Google Scholar 

  33. D’Avanzo B, La Vecchia C (1995) Risk factors for male breast cancer. Br J Cancer 71(6):1359–1362

    PubMed  CAS  Google Scholar 

  34. Sasco AJ, Lowenfels AB, Pasker-de Jong P (1993) Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 53(4):538–549

    Article  PubMed  CAS  Google Scholar 

  35. Schottenfeld D, Lilienfeld AM, Diamond H (1963) Some observations on the epidemiology of breast cancer among males. Am J Public Health 53:890–897

    Article  PubMed  CAS  Google Scholar 

  36. Storm HH, Olsen J (1999) Risk of breast cancer in offspring of male breast-cancer patients. Lancet 353(9148):209

    Article  PubMed  CAS  Google Scholar 

  37. Hemminki K, Vaittinen P (1999) Male breast cancer: risk to daughters. Lancet 353(9159):1186–1187

    Article  PubMed  CAS  Google Scholar 

  38. Travis LB, Hill DA, Dores GM et al (2003) Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290(4):465–475

    Article  PubMed  Google Scholar 

  39. Auvinen A, Curtis RE, Ron E (2002) Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst 94(17):1330–1332

    PubMed  Google Scholar 

  40. Struewing JP, Brody LC, Erdos MR et al (1995) Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet 57(1):1–7

    PubMed  CAS  Google Scholar 

  41. Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62(3):676–689

    CAS  Google Scholar 

  42. Osorio A, Barroso A, Martinez B et al (2000) Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families. Br J Cancer 82(7):1266–1270

    Article  PubMed  CAS  Google Scholar 

  43. Sasano H, Kimura M, Shizawa S et al (1996) Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study. J Clin Endocrinol Metab 81(8):3063–3067

    Article  PubMed  CAS  Google Scholar 

  44. Anderson WF, Althuis MD, Brinton LA et al (2004) Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 83(1):77–86

    Article  PubMed  Google Scholar 

  45. Ribeiro G, Swindell R (1992) Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer 65(2):252–254

    PubMed  CAS  Google Scholar 

  46. Nahleh ZA (2006) Hormonal therapy for male breast cancer: a different approach for a different disease. Cancer Treat Rev 32(2):101–105

    Article  PubMed  CAS  Google Scholar 

  47. Munoz de Toro MM, Maffini MV, Kass L et al (1998) Proliferative activity and steroid hormone receptor status in male breast carcinoma. J Steroid Biochem Mol Biol 67(4):333–339

    Article  Google Scholar 

  48. Weber-Chappuis K, Bieri-Burger S, Hurlimann J (1996) Comparison of prognostic markers detected by immunohistochemistry in male and female breast carcinomas. Eur J Cancer 32A(10):1686–1692

    Article  PubMed  CAS  Google Scholar 

  49. http://www.swog.org/Visitors/ViewProtocolDetails.asp?ProtocolID=1995

Download references

Acknowledgments

This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.

Author information

Authors and Affiliations

  1. Breast Cancer Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 8, Rm 5101, 8901 Wisconsin Ave, Bethesda, MD , 20889, USA

    Janice M. Walshe, Arlene W. Berman, Ujala Vatas & Sandra M. Swain

  2. Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD , 20889, USA

    Seth M. Steinberg

  3. Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD , 20889, USA

    William F. Anderson

  4. University of Michigan, Ann Arbor, MI , 48109, USA

    Marc E. Lippman

Authors
  1. Janice M. Walshe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arlene W. Berman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ujala Vatas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seth M. Steinberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. William F. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marc E. Lippman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sandra M. Swain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sandra M. Swain.

Additional information

The U.S. Government's right to retain a non-exclusive, royalty-free license in and to any copyright is acknowledged.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walshe, J.M., Berman, A.W., Vatas, U. et al. A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up. Breast Cancer Res Treat 103, 177–183 (2007). https://doi.org/10.1007/s10549-006-9363-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-006-9363-0

Keywords

Search

Navigation